|
ViroPharma, Inc.
Ticker Symbol: VPHM* CUSIP: 928241108 Exchange: NGS
* NOTE: This security is no longer trading as of 1/24/14
Company's Online Profile
BUSINESS: ViroPharma Incorporated is a global biotechnology company. The Company is engaged in the development and commercialization of products that address diseases, with a focus on products used by physician specialists or in hospital settings. The Company markets and sells Cinryze in the United States for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema,
|
Notes: January 24, 2014 -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces the successful completion of the tender offer for all of the outstanding shares of ViroPharma (VPHM). Shire expects to complete the merger of ViroPharma with one of its subsidiaries today, and, in connection with the merger, all remaining common shares of ViroPharma (excluding shares held by ViroPharma, Shire or certain of their respective subsidiaries or holders who have properly demanded appraisal rights under Delaware law) will be converted into the right to receive $50 per share in cash, the same price that was paid in the tender offer. Following completion of the merger, ViroPharma will become a wholly owned subsidiary of Shire and its shares will cease to be traded on NASDAQ.
|
IPO - 1/1/1900
Large Cap Stock -
Market Value $ 2.1 Billion
Yahoo News Summary for VPHM*
YAHOO! Profile for VPHM*
Yahoo Detailed Quote
MarketWatch Quote
MSN Company Report for VPHM*
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 730 Stockton Drive, Exton, PA 19341 |
| Main Phone Number |
610-458-7300 |
| Fax Number |
610-458-7380 |
| Investor Relations
Bob Doody
|
610-321-6290
|
Toll Free Phone Number |
Unknown |
| CEO - Vincent J. Milano |
CFO - Charles A. Rowland Jr. |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
